CVM

CEL SCI
AMEX

Real-time Quotes | Nasdaq Last Sale

9.75
-0.45
-4.41%
After Hours: 9.80 +0.05 +0.51% 18:17 04/03 EDT
OPEN
10.28
PREV CLOSE
10.20
HIGH
10.30
LOW
9.66
VOLUME
444.18K
TURNOVER
--
52 WEEK HIGH
17.80
52 WEEK LOW
3.695
MARKET CAP
363.77M
P/E (TTM)
-11.0369
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CVM News

More
  • CEL-SCI Announces Change of Location to 2020 Annual Meeting of Shareholders
  • Business Wire · 4d ago
  • CEL-SCI Announces the Closing of Its $7.7 Million Bought Deal
  • Business Wire · 03/26 16:05
  • Cel-Sci down 4% premarket on equity offering
  • seekingalpha · 03/24 16:00
  • CEL-SCI Increases Previously Announced Bought Deal to $7.7 Million
  • Business Wire · 03/24 14:25

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About CVM

CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for treatment of certain head and neck cancers, and anal warts or cervical dysplasia in human immunodeficiency virus and human papillomavirus co-infected patients and Ligand Epitope Antigen Presentation System (L.E.A.P.S.) technology, with over two investigational therapies, LEAPS-H1N1-DC, a product candidate under development for treatment of pandemic influenza in hospitalized patients, and CEL-2000 and CEL-4000, vaccine product candidates under development for treatment of rheumatoid arthritis.
More

Webull offers kinds of CEL-SCI Corporation stock information, including AMEX:CVM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CVM stock news, and many more online research tools to help you make informed decisions.